Biomarkers


Biomarkers in basic and clinical research as well as in clinical practice has become so commonplace that their presence as primary endpoints in clinical trials. Biomarkers that have been well characterized and repeatedly shown to correctly predict relevant clinical outcomes across a variety of treatments and populations; this use is entirely justified and appropriate. It is easy to imagine measurable Biological characteristics that do not correspond to patients' clinical state, or whose variations are undetectable and without effect on health. Surrogate endpoints are a small subset of well-characterized Biomarkers with well-evaluated clinical relevance. A Biomarker consistently and accurately predicts a clinical outcome, either a Benefit or harm.


    Related Conference of Biomarkers

    July 25-26, 2024

    23rd International Conference on Big Data & Data Analytics

    Amsterdam, Netherlands
    September 19-20, 2024

    11th Global Innovators Summit

    London, UK
    October 14-15, 2024

    5th International Congress onAI and Machine Learning

    Paris, France
    November 20-21, 2024

    5th World Congress on Robotics and Automation

    Paris, France

    Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in